(Q40977563)

25 September 2017

Regulation of the c-met proto-oncogene promoter by p53. (English)

1 reference

25 September 2017

Seol DW

1

1 reference

25 September 2017

Chen Q

series ordinal

2

1 reference

25 September 2017

Smith ML

series ordinal

3

1 reference

25 September 2017

Zarnegar R

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Journal of Biological Chemistry

25 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

274

1 reference

25 September 2017

3565-3572

1 reference

25 September 2017

6

1 reference

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

25 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Molecular cloning of a new transforming gene from a chemically transformed human cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Tyrosine kinase receptor indistinguishable from the c-met protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Sequence-specific transcriptional activation is essential for growth suppression by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Identification of a cell-type-specific transcriptional repressor in the promoter region of the mouse hepatocyte growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Induction of the growth inhibitor IGF-binding protein 3 by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Growth inhibition and induction of apoptosis by HGF in transformed rat liver epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

The p53-Regulated Cyclin G Gene Promotes Cell Growth: p53 Downstream Effectors Cyclin G and Gadd45 Exert Different Effects on Cisplatin Chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3565

21 January 2018

Identifiers

DOI

10.1074/JBC.274.6.3565

1 reference

25 September 2017

1 reference